Your browser doesn't support javascript.
loading
Therapeutic drug monitoring guidelines in oncology: what do we know and how to move forward? Insights from a systematic review.
Li, Xinya; Song, Zaiwei; Yi, Zhanmiao; Qin, Jiguang; Jiang, Dan; Wang, Zhitong; Li, Huibo; Zhao, Rongsheng.
Affiliation
  • Li X; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Song Z; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.
  • Yi Z; Therapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, China.
  • Qin J; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Jiang D; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Wang Z; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.
  • Li H; Therapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, China.
  • Zhao R; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
Ther Adv Med Oncol ; 16: 17588359241250130, 2024.
Article in En | MEDLINE | ID: mdl-38812991
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ther Adv Med Oncol Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ther Adv Med Oncol Year: 2024 Document type: Article Affiliation country: Country of publication: